Question 1

What is the Meaning of HORIZON-PFT Extension Trial?

Accepted Answer

The HORIZON-PFT Extension Trial is a prolonged clinical investigation assessing long-term safety and sustained efficacy of a specific therapeutic agent, likely related to parathyroid hormone or bone metabolism. This trial provides essential data on treatment benefit durability and emergence of delayed adverse events, building upon an initial pivotal study.

Question 2

What is the Context of HORIZON-PFT Extension Trial?

Accepted Answer

This extension trial operates within pharmaceutical development for skeletal health conditions, notably osteoporosis. It gathers comprehensive data beyond initial registration trials, offering a complete understanding of the therapeutic agent's profile over several years. This influences its integration into standard clinical practice for chronic conditions.

Question 3

What is the Significance of HORIZON-PFT Extension Trial?

Accepted Answer

The practical importance of this extension trial lies in confirming sustained clinical benefit and long-term safety of the intervention, crucial for patients needing prolonged therapy for bone density or fracture risk reduction. Data informs clinical guidelines, assists prescribers, and assures patients regarding enduring treatment effects, improving long-term skeletal well-being.

Question 4

What is the Mechanism of HORIZON-PFT Extension Trial?

Accepted Answer

The extension trial mechanism involves continuing study medication or observation for participants from an initial trial, systematically collecting ongoing clinical, biochemical, and imaging data. This continuous monitoring allows researchers to observe sustained physiological impact on bone remodeling, assess long-term changes in bone mineral density, and identify prolonged effects on calcium and phosphate homeostasis.

Question 5

What is the Application of HORIZON-PFT Extension Trial?

Accepted Answer

In clinical practice, the HORIZON-PFT Extension Trial provides evidence supporting prolonged use of the investigated therapy for individuals with chronic bone conditions. Patients from the core trial are typically offered enrollment to continue receiving the study drug or an alternative, enabling extended surveillance of bone health parameters and physiological responses, guiding long-term therapeutic strategies.

Question 6

What is the Metric of HORIZON-PFT Extension Trial?

Accepted Answer

Effects and safety in the HORIZON-PFT Extension Trial are measured via serial bone mineral density (BMD) assessments using DXA scans, focusing on lumbar spine and hip. New vertebral and non-vertebral fracture incidence is documented. Serum biomarkers like P1NP and CTX, with calcium and parathyroid hormone levels, are regularly monitored to evaluate physiological response.

Question 7

What is the Risk of HORIZON-PFT Extension Trial?

Accepted Answer

Potential risks include prolonged study medication exposure, potentially uncovering rare or delayed adverse reactions not seen in shorter trials, or an unforeseen lack of sustained efficacy. For patients, discontinuing effective therapy upon trial completion without a clear alternative can pose a risk to bone health, underscoring the importance of ongoing clinical supervision.

HORIZON-PFT Extension Trial

Meaning

Context

Significance

Mechanism

Application

Metric

Risk

When Should a Bisphosphonate Treatment Pause Be Considered for Patients?

Provided by the clinical team
at 4Ever Young Miami Dadeland

-15% ∞ HRTIO15

Your protocol begins with a conversation.

Visit

Schedule Appointment

About

Med & Wellness

4Ever Young Miami Dadeland

Communication

+1 786-529-6686

Email Us

Opening Hours